Route Fifty: In June, officials in Louisiana unveiled a deal several years in the making: the state would partner with a pharmaceutical company to provide unlimited amounts of hepatitis C drugs to its prison and Medicaid populations over a five-year period.
Under the terms of the deal, Louisiana will pay roughly $60 million each year, approximately what the state spent on treatments for the infectious disease in the last fiscal year.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now